Zurück
HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 659754Erstellt: 23. Oktober 2026

Piperazine Dihydrochloride → Irbesartan

https://huagongshe.com/de/reaction/659754

Reaktionsgleichung

Beteiligte Stoffe

RolleNameHCIDEinwaage
EduktPiperazine DihydrochlorideHCID 8893—
EduktSodium AzideHCID 33557—
Edukt4'-((2-Butyl-4-oxo-1,3-diazaspiro(4.4)non-1-ene-3-yl)methyl)(1,1'-biphenyl)-2-carbonitrileHCID 9843116—
LösungsmittelO-XyleneHCID 7237—
ProduktIrbesartanHCID 374996%

Reaktionsschritte

A mixture of 2-n-butyl-3-[(2′-cyanobiphenyl-4-yl)methyl]-1,3-diazaspiro-[4,4]-non-1-en-4-one (10 g), sodium azide (7.7 g) and piperazine dihydrochloride (7.5 g) in xylene (30 ml) was refluxed for 7 hours under stirring. The reaction was cooled to room temperature and extracted with 5% NaOH solution. The pooled alkaline solution was washed with toluene or xylene (15 ml) and the aqueous phase neutralized to pH 6.5 using concentrated HCL. The resulting suspension was stirred for 3 hours at room temperature and filtered obtain irbesartan (3.6 g, 96% purity by HPLC).

Herkunft & Nachweise

DOI10.6084/m9.figshare.5104873.v1
PatentnummerUS08080670B2
Quelldatensatzuspto-grants-2011_12
ORD IDord-a67296b3abe540c4a17ddd7e7fd19fb6
Quellennotizuspto-grants-2011_12